Effectiveness of antiarrhythmic agents in preventing death in ventricular fibrillation induced by isoprenaline in desoxycorticosterone-pretreated rats.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D003900:Desoxycorticosterone; D004353:Drug Evaluation, Preclinical / Q000379:methods; D007545:Isoproterenol; D008274:Magnesium / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D003900:Desoxycorticosterone; D008274:Magnesium; D007545:Isoproterenol; D011188:Potassium